Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Company Information & History

Rznomics was established in August 2017 to develop gene therapy products using RNA

This is a biotechnology company founded by professor Lee Sung-wook's lab We are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

CEO
Lee, Seong-Wook
Established date
2017.8.29
Business Area
Development of RNA replacement enzyme vector-based anticancer gene therapy Technology transfer and patents from Dankook university (2017. 10. 11)
Head Office
607, 17-17, Cheomdanqwagi-ro, 208 beon-gil, Buk-gu, Gwangju, 61011, Korea
Innopolis Research Company Registration Registered R&D Special Zone (Gwangju Innopolis) Research Company (2017.11.23)
R&D Project TIPS program (Tech Incubator Program for startup Korea) Ministry of SMEs and Startups (2017. 12. 22)
Company affiliated Research Institute Accreditaion 314, Software ICT Hall, 152, Jukjeon-ro, Suji-gu, Yongin, 16890, Korea (2018. 5. 21)
Venture Enterprise Certification Acquired Korean Venture Capital Association corporate certification (2018.5.24)
IP Status Korea Patent Registration 1 case, US pending1 case, EU pending 1 case, Japan pending 1 case